Anaergia Inc. (TSX:ANRG)

Ligand Pharmaceuticals Revenue

Anaergia had revenue of 24.88M CAD in the quarter ending March 31, 2025, a decrease of -0.37%. This brings the company's revenue in the last twelve months to 111.55M, down -17.26% year-over-year. In the year 2024, Anaergia had annual revenue of 111.65M, down -24.17%.

• Revenue (ttm): 111.55M
• Revenue Growth: -17.26%
• P/S Ratio: 2.06
• Revenue / Employee: 395.58K
• Employees: 282
• Market Cap: 229.46M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	111.65M	-35.58M	-24.17%
Dec 31, 2023	147.23M	-14.88M	-9.18%
Dec 31, 2022	162.10M	32.23M	24.82%
Dec 31, 2021	129.87M	19.34M	17.50%
Dec 31, 2020	110.53M	20.86M	23.26%